Expert consensus on the clinical application of Tianmeng oral liquid in psychosomatic disorders
Journal of Clinical and Basic Psychosomatics · 31.03.2026 · 4 (2) · 026030003
DOI: 10.36922/jcbp026030003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical and Basic Psychosomatics, online erschienen am 31.03.2026. Verfasst von Zhenghua Hou und 32 weiteren Autor:innen.
Abstract (Originalsprache)
Psychosomatic disorders are characterized by complex interactions between psychological factors and somatic symptoms and frequently present with comorbid insomnia, anxiety, and depressive symptoms. Although conventional pharmacological treatments are widely used, their limitations highlight the need for integrative therapeutic approaches. Tianmeng oral liquid, a multi-component Chinese herbal formulation, has been increasingly used in clinical practice for the treatment of psychosomatic symptoms. This review aims to develop expert consensus on the clinical application of Tianmeng oral liquid in the treatment of psychosomatic disorders. This consensus was developed through a comprehensive review of the literature, evaluation of available clinical and experimental evidence, and structured expert panel discussions. Recommendations were formulated based on evidence strength, clinical experience, and principles of psychosomatic medicine. Tianmeng oral liquid exhibits a multi-target pharmacological profile, modulating central nervous system activity, neuroendocrine regulation, and immune homeostasis. Available evidence suggests that it may improve sleep quality, alleviate anxiety and depressive symptoms, and enhance overall well-being in patients with psychosomatic disorders. The formulation may be used as monotherapy in mild cases or as an adjunct to standard pharmacological and psychological interventions. It is generally well tolerated when administered according to recommended dosing strategies. Tianmeng oral liquid may be considered a complementary therapeutic option within a comprehensive biopsychosocial treatment framework for psychosomatic disorders. Further high-quality randomized controlled trials and mechanistic studies are warranted to strengthen the evidence base and refine clinical application strategies.
Zitieren
APA
Hou, Z., Zhang, L., Ai, S., Fang, M., Guo, R., Huang, M., Jiang, W., Li, X., Liu, J., Liu, P., Liu, X., Lv, D., Qiao, L., Su, Q., Sun, L., Tao, J., Teng, J., Wang, H., Wang, C., …, & Yuan, Y. (2026). Expert consensus on the clinical application of Tianmeng oral liquid in psychosomatic disorders. Journal of Clinical and Basic Psychosomatics, 4(2), 026030003. https://doi.org/10.36922/jcbp026030003
Vancouver
Hou Z, Zhang L, Ai S, Fang M, Guo R, Huang M, et al. Expert consensus on the clinical application of Tianmeng oral liquid in psychosomatic disorders. Journal of Clinical and Basic Psychosomatics. 2026;4(2):026030003. doi:10.36922/jcbp026030003
BibTeX
@article{Hou2026,
author = {Hou, Zhenghua and Zhang, Leyi and Ai, Sizhi and Fang, Maosheng and Guo, Rongjuan and Huang, Manli and Jiang, Wenjing and Li, Xiuli and Liu, Jin and Liu, Ping and Liu, Xiangzhe and Lv, Dongsheng and Qiao, Lijun and Su, Qinji and Sun, Lu and Tao, Jiong and Teng, Jing and Wang, Han and Wang, Chuansheng and Wang, Huaning and Xiong, Peng and Xu, Fengquan and Yi, Zhenghui and Zhang, Jie and Zhang, Yupeng and Zhao, Min and Zhao, Peng and Zhao, Yuehan and Zhou, Bo and Zou, Shaohong and Zou, Wei and Guo, Wenbin and Yuan, Yonggui},
title = {Expert consensus on the clinical application of Tianmeng oral liquid in psychosomatic disorders},
journal = {Journal of Clinical and Basic Psychosomatics},
year = {2026},
volume = {4},
number = {2},
pages = {026030003},
doi = {10.36922/jcbp026030003}
}
EUVIMED